Definitely on the same page NZ...,
Quarter out end of month, as u stated inked hence management is commended IMO also.
Regardless of the frustration by some (decline in SP), the process in biotech towards commercialisation is long and only few achieve.
Results validated is next big box to tick for us, the rest is already in place.
Luck to all that hold.
Ann: Appendix 3X & 3Z, page-6
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |